(Alliance News) - Imaging Biometrics Ltd on Thursday noted the use of its Functional Tumor Burden mapping technology in a glioblastoma clinical trial at Cooper University's MD Anderson Cancer Center.

Google is silently rolling out Gemini 3 to mobile Canvas users, showing dramatic performance improvements in web design and ...

Imaging Biometrics Ltd (LSE:IBAI, OTCQB:IQAIF) shares rose 13% to 1.02p on Thursday after the company announced that its fractional tumour burden ...

Imaging Biometrics Ltd (LSE:IBAI, OTCQB:IQAIF) shares rose 13% to 1.02p on Thursday after the company announced that its fractional tumour burden ...